Human DNA topoisomerase I: relaxation, roles, and damage control

被引:0
|
作者
John B. Leppard
James J. Champoux
机构
[1] University of Washington,Department of Microbiology, School of Medicine
来源
Chromosoma | 2005年 / 114卷
关键词
Camptothecin; Replication Fork; Fluorescence Recovery After Photobleaching; rDNA Transcription; Linker Domain;
D O I
暂无
中图分类号
学科分类号
摘要
Human DNA topoisomerase I is an essential enzyme involved in resolving the torsional stress associated with DNA replication, transcription, and chromatin condensation. The catalytic cycle of the enzyme consists of DNA cleavage to form a covalent enzyme–DNA intermediate, DNA relaxation, and finally, religation of the phosphate backbone to restore the continuity of the DNA. Structure/function studies have elucidated a flexible enzyme that relaxes DNA through coordinated, controlled movements of distinct enzyme domains. The cellular roles of topoisomerase I are apparent throughout the nucleus, but the concentration of processes acting on ribosomal DNA results in topoisomerase I accumulation in the nucleolus. Although the activity of topoisomerase I is required in these processes, the enzyme can also have a deleterious effect on cells. In the event that the final religation step of the reaction cycle is prevented, the covalent topoisomerase I–DNA intermediate becomes a toxic DNA lesion that must be repaired. The complexities of the relaxation reaction, the cellular roles, and the pathways that must exist to repair topoisomerase I-mediated DNA damage highlight the importance of continued study of this essential enzyme.
引用
收藏
页码:75 / 85
页数:10
相关论文
共 50 条
  • [21] Processing of topoisomerase I cleavable complexes into DNA damage by transcription
    Wu, JX
    Liu, LF
    NUCLEIC ACIDS RESEARCH, 1997, 25 (21) : 4181 - 4186
  • [22] Topoisomerase I-mediated DNA damage and repair.
    Pommier, Y
    CLINICAL CANCER RESEARCH, 2000, 6 : 4479S - 4479S
  • [23] DNA TOPOISOMERASE-I FROM HUMAN PLACENTA
    HOLDEN, JA
    ROLFSON, DH
    LOW, RL
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1049 (03) : 303 - 310
  • [24] DOXORUBICIN INHIBITS HUMAN DNA TOPOISOMERASE-I
    FOGLESONG, PD
    RECKORD, C
    SWINK, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (02) : 123 - 125
  • [25] Targeting Covalent Complex of Human Topoisomerase I with DNA
    Tiwari, Purushottam
    Tse-Dinh, Yuk-Ching
    Uren, Aykut
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 302A - 303A
  • [26] Isodiospyrin as a novel human DNA topoisomerase I inhibitor
    Ting, CY
    Hsu, CT
    Hsu, HT
    Su, JS
    Chen, TY
    Tarn, WY
    Kuo, YH
    Whang-Peng, J
    Liu, LF
    Hwang, JL
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (10) : 1981 - 1991
  • [27] Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II
    Lee, Joyce H.
    Berger, James M.
    GENES, 2019, 10 (11)
  • [28] Unraveling the role of FUS in DNA damage induced by topoisomerase I inhibitor
    Yuan, Xincheng
    Djaja, Nathalie A.
    Myong, Sua
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 221A - 221A
  • [29] Mercury(II) Impairs Processing of DNA damage Induced by Topoisomerase I
    Ursu, Giorgiana Madalina
    Zhitkovich, Anatoly
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2024, 65 : 87 - 88
  • [30] Repair of and checkpoint response to topoisomerase I-mediated DNA damage
    Pommier, Y
    Redon, C
    Rao, VA
    Seiler, JA
    Sordet, O
    Takemura, H
    Antony, S
    Meng, LH
    Liao, ZY
    Kohlhagen, G
    Zhang, HL
    Kohn, KW
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2003, 532 (1-2) : 173 - 203